Insider Trading activities of G1 Therapeutics, Inc. insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of G1 Therapeutics, Inc. since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of G1 Therapeutics, Inc. since year 2005. Table 2 shows the detailed insider transactions of G1 Therapeutics, Inc. since 2005. The reporting company's ticker symbol is GTHX. The reporting company's CIK number is 1560241.
The total value of stock buying since 2005 is $23,357,495.
The total value of stock sales since 2005 is $6,646,643.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for G1 Therapeutics, Inc. (GTHX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-12 0 $0 133,906 $2,644,643 0 $0
2017-11 250,000 $4,932,500 200,000 $4,002,000 0 $0
2017-05 1,228,333 $18,424,995 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of G1 Therapeutics, Inc. insiders (GTHX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-12-01 Medimmune Ventures, Inc. (10% Owner) Sale 133,906 19.75 2,644,643
2017-11-20 Medimmune Ventures, Inc. (10% Owner) Sale 200,000 20.01 4,002,000
2017-11-13 Eshelman Fredric N (Director) Buy 250,000 19.73 4,932,500
2017-05-22 Eshelman Ventures, Llc (10% Owner) Buy 300,000 15.00 4,500,000
2017-05-22 Kolchinsky Peter Buy 400,000 15.00 6,000,000
2017-05-22 Medimmune Ventures, Inc. (10% Owner) Buy 75,000 15.00 1,125,000
2017-05-22 Reed Douglas Md (10% Owner) Buy 133,333 15.00 1,999,995
2017-05-22 Muir Glenn P (Director) Buy 20,000 15.00 300,000
2017-05-22 Eshelman Fredric N (Director) Buy 300,000 15.00 4,500,000

Insider trading activities including stock purchases, stock sales, and option exercises of GTHX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of G1 Therapeutics, Inc. (symbol GTHX, CIK number 1560241) see the Securities and Exchange Commission (SEC) website.